Illinois 340B laws

Three Illinois laws name the 340B program. Here is what each one does, who it applies to and where to read it.

215 ILCS 5/513b1 and 5/424; 305 ILCS 5/5-36

A contract between a pharmacy benefit manager or third-party payer and a 340B entity or 340B pharmacy may not pay it less, add fees or chargebacks, limit a patient's choice, keep it out of a network or otherwise treat it differently for taking part in 340B. A separate subsection sets the same rule for Medicaid managed care organizations.

Bill
HB 4595
Act
Public Act 102-0778
Session
2022
Signed
13 May 2022
In effect
1 July 2022
Applies to
Pharmacy benefit managers and third-party payers; Medicaid managed care organizations
Limits
A term that breaks the rule is void in contracts entered into, amended or renewed after July 1, 2022.
Enforcement
A breach by a pharmacy benefit manager is an unfair or deceptive act in the business of insurance.

A provision that violates subsection (f) in a contract between a pharmacy benefit manager or a third-party payer and a 340B entity that is entered into, amended, or renewed after July 1, 2022 shall be void and unenforceable

From the law’s text

Patient Access to Pharmacy Protection Act

No person, a drug manufacturer included, may deny, restrict or place conditions on 340B drugs reaching a covered entity or its contract pharmacy, limit the number or place of contract pharmacies, or demand pricing or claims data. Covered entities file a yearly 340B report with the General Assembly and keep a policy against duplicate discounts; the state Medicaid agency reports once on 340B units and savings.

Bill
HB 2371
Act
Public Act 104-0758
Session
2026
In effect
7 August 2026
Applies to
Drug manufacturers and any other person; 340B covered entities; the Department of Healthcare and Family Services
Limits
Hospitals with fewer than 100 licensed beds, Critical Access Hospitals, Safety-Net Hospitals and 340B grantees need not report until January 1, 2029. The Medicaid report is due by January 1, 2028. 340B dispensing is limited to patients who had an outpatient service in the last 18 months.
Enforcement
The Attorney General enforces. A court may order an injunction, damages to the covered entity and a civil penalty of up to $1,000 for each violation.

No person, including a pharmaceutical manufacturer, may deny, restrict, prohibit, condition, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B covered entity or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B covered entity unless the receipt is prohibited by federal law

From the law’s text

340B Transparency, Reporting, and Accountability Act

The Department of Insurance studies how 340B covered entities and drug manufacturers in Illinois take part in the program and reports to the General Assembly and the Governor by July 1, 2028. Covered entities and manufacturers answer its requests on acquisition cost, payments received, contract pharmacies and the use of savings.

Bill
HB 4327
Act
Public Act 104-0769
Session
2026
In effect
7 August 2026
Applies to
The Department of Insurance; 340B covered entities and drug manufacturers in Illinois
Limits
The act is repealed on July 1, 2032. It does not regulate pricing, reimbursement or participation in the federal program.
Enforcement
An answer more than 30 days late draws a fine of $500 a day, or $100 a day for small hospitals, Critical Access Hospitals, Safety-Net Hospitals and 340B grantees.

the Department of Insurance shall conduct a comprehensive study of how 340B covered entities and pharmaceutical manufacturers within Illinois participate in the 340B Drug Discount Program

From the law’s text

Plain-language summaries, not legal advice. Laws change, and court rulings on them are not covered here. Read the state’s own page before you rely on one.

See something missing or out of date? Tell us.